News

Search Results

DOH Statewide Distribution of Free COVID-19 Tests Continues

The South Dakota Department of Health (SD-DOH) continued its operations to distribute one million Flowflex® COVID-19 Antigen home tests to sites across the state.

January 28, 2022 | COVID-19 | Immunizations and Vaccines

Department of Health Begins Statewide Distribution of One Million Free COVID-19 Tests

Today, the South Dakota Department of Health (SD-DOH) began operations to promptly and efficiently distribute one million Flowflex® COVID-19 antigen home tests to sites across the state.

January 21, 2022 | COVID-19 | Immunizations and Vaccines

Department of Health Makes an Additional One Million Free COVID-19 Tests Available to State Resident

Today, the South Dakota Department of Health (DOH) announced it has procured one million Flowflex® COVID-19 Antigen home tests.

January 7, 2022 | COVID-19 | Immunizations and Vaccines

CDC Expands Booster Shot Eligibility and Strengthens Recommendations for 12-17 Year Olds

Today, CDC is endorsing the Advisory Committee on Immunization Practices’ (ACIP) recommendation to expand eligibility of booster doses to those 12 to 15 years old. CDC now recommends that adolescents age 12 to 17 years old should receive a booster shot 5 months after their initial Pfizer-BioNTech vaccination series.

January 5, 2022 | COVID-19 | Immunizations and Vaccines

CDC Recommends Pfizer Booster at 5 Months, Additional Primary Dose for Certain Immunocompromised Children

CDC is updating our recommendation for when many people can receive a booster shot, shortening the interval from 6 months to 5 months for people who received the Pfizer-BioNTech COVID-19 Vaccine.

January 4, 2022 | COVID-19

Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19

Given what we currently know about COVID-19 and the Omicron variant, CDC is shortening the recommended time for isolation for the public.

December 27, 2021 | COVID-19 | Immunizations and Vaccines

Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults

The FDA issued an emergency use authorization for Merck’s molnupiravir for the treatment of mild-to-moderate COVID-19 in certain adults.

December 23, 2021 | COVID-19 | Immunizations and Vaccines

First COVID-19 Omicron Variant Case Detected in South Dakota

First COVID-19 OmicronVariant Case Detected in South Dakota

December 22, 2021 | COVID-19 | Immunizations and Vaccines

CDC Updates and Shortens Recommended Isolation and Quarantine Period for General Population

Today, the FDA issued an emergency use authorization for the first oral antiviral for treatment of COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds).

December 22, 2021 | COVID-19 | Immunizations and Vaccines

South Dakota Reports First Flu Death of Season

Today, the South Dakota Department of Health reported the first influenza death of the 2021-2022 season.

December 16, 2021 | Infectious Disease

Filter by Topic